Deutsch
 
Mein Konto  

ANMELDEN & VORTEILE SICHERN

  • Preise & Rabatte einsehen
  • Geschenke sichern
  • Angebote anfragen & online annehmen
JETZT ANMELDEN Noch nicht registriert? Konto hier erstellen!
Vergleich
Ergebnisse

Ergebnisse filtern

Typ
Specific against
Host
Clone
  1. 1(23)
  2. 10(9)
  3. 10C12(4)
  4. 10F.9G2(23)
  5. 116-13.1(10)
  6. 11B11(20)
  7. 12G5(5)
  8. 14-4-4S(10)
  9. 145-2C11(19)
  10. 15(9)
  11. 15-3-1S(4)
  12. 15A7(4)
  13. 16-10A1(19)
  14. 178 (LALAPG)(5)
  15. 17A2(8)
  16. 18B12(7)
  17. 1a3(5)
  18. 1A8(19)
  19. 1D11.1(5)
  20. 1D11.16.8(10)
  21. 1D3(14)
  22. 1F6(9)
  23. 1G9(26)
  24. 1H1(6)
  25. 2(23)
  26. 2.4G2(19)
  27. 20D5(14)
  28. 20H2(5)
  29. 225(4)
  30. 22D1(19)
  31. 24(5)
  32. 29E.2A3(16)
  33. 29F.1A12(19)
  34. 2D5(10)
  35. 2D5-1.9(9)
  36. 2H7(19)
  37. 3(28)
  38. 30-H12(19)
  39. 33D1(40)
  40. 37(9)
  41. 38(5)
  42. 38/42(4)
  43. 384-35(5)
  44. 3E8#(4)
  45. 3G8(15)
  46. 3H10.1(19)
  47. 3H3(19)
  48. 4(5)
  49. 43(9)
  50. 480(14)
  51. 4A9(18)
  52. 4E1.2(9)
  53. 4LO3311(18)
  54. 50-6(5)
  55. 500A2(20)
  56. 509F6(8)
  57. 51(9)
  58. 53-5.8(19)
  59. 53-6.7(19)
  60. 55R-170(15)
  61. 55R-593(15)
  62. 5C8(3)
  63. 5G11(11)
  64. 6B11(5)
  65. 7B10(15)
  66. 7E.17G9(19)
  67. 7G7B6(19)
  68. 8C8(9)
  69. 9(5)
  70. 9000000000(10)
  71. 927(18)
  72. 9a2(9)
  73. 9D9(19)
  74. 9E9(8)
  75. 9H10(23)
  76. A4C8.1-Do9(10)
  77. A7R34(6)
  78. Abituzumab(3)
  79. Abrilumab(3)
  80. Aducanumab(3)
  81. AF6-88.5(9)
  82. Afasevikumab(3)
  83. AFS98(19)
  84. ALF-161(10)
  85. Amatuximab(3)
  86. Anifrolumab(3)
  87. Anrukinzumab(3)
  88. Apamistamab(3)
  89. Aprutumab(3)
  90. Atezolizumab(3)
  91. Atibuclimab(3)
  92. Avelumab(3)
  93. Avizakimab(3)
  94. B122(10)
  95. B22/249(14)
  96. B6H12(21)
  97. B7/21(5)
  98. B8-24-3(14)
  99. B8.2C12(5)
  100. Bamlanivimab(3)
  101. Bapineuzumab(3)
  102. Basiliximab(3)
  103. Batoclimab(3)
  104. Bavbio(5)
  105. Bavituximab(3)
  106. BC8(19)
  107. BE29G1(15)
  108. Begelomab(3)
  109. Belantamab(3)
  110. Belimumab(3)
  111. Bemarituzumab(3)
  112. Bermekimab(3)
  113. Bersanlimab(3)
  114. Bertilimumab(3)
  115. Bevacizumab(3)
  116. Bexmarilimab(3)
  117. Bimekizumab(3)
  118. Bivatuzumab(3)
  119. Bleselumab(3)
  120. Blosozumab(3)
  121. Bococizumab(3)
  122. Brazikumab(3)
  123. Brentuximab(3)
  124. Briakinumab(3)
  125. Brodalumab(3)
  126. Burosumab(3)
  127. BVD6-24G2(4)
  128. C1.18.4(11)
  129. C17.8(7)
  130. C71/16(16)
  131. C9B7W(18)
  132. Cadbio(5)
  133. Camidanlumab(3)
  134. Camrelizumab(3)
  135. Canakinumab(3)
  136. Caplacizumab(7)
  137. Carlumab(3)
  138. CD28.2(7)
  139. Cedelizumab(3)
  140. Cemiplimab(3)
  141. Cendakimab(3)
  142. Cetuximab(3)
  143. CHK-166(10)
  144. CHK152(5)
  145. Cibbio(5)
  146. Cixutumumab(3)
  147. Clazakizumab(3)
  148. Clenoliximab(3)
  149. Clervonafusp Alfa(4)
  150. Clesrovimab(3)
  151. Codrituzumab(3)
  152. Coltuximab(3)
  153. Cusatuzumab(3)
  154. CXCR3-173(18)
  155. Cy34.1(22)
  156. D12(4)
  157. D5(10)
  158. Dacetuzumab(3)
  159. Daclizumab(3)
  160. Daratumumab(3)
  161. DATK32(15)
  162. Daxdilimab(3)
  163. DC101(14)
  164. Dectrekumab(3)
  165. Denintuzumab(3)
  166. Denosumab(3)
  167. DREG56(5)
  168. Dupilumab(3)
  169. Durvalumab(3)
  170. Dusigitumab(3)
  171. E18(10)
  172. Edrecolomab(3)
  173. Efalizumab(3)
  174. EGFR.1(14)
  175. Eldelumab(3)
  176. Elipovimab(3)
  177. Elotuzumab(3)
  178. Emapalumab(3)
  179. Emibetuzumab(3)
  180. Enfortumab(3)
  181. Enibarcimab(3)
  182. Enoblituzumab(3)
  183. Enokizumab(3)
  184. Epratuzumab(5)
  185. Eptinezumab(3)
  186. Erenumab(3)
  187. ERIC-1(11)
  188. Erlizumab(3)
  189. Etaracizumab(3)
  190. Etokimab(3)
  191. Etrolizumab(3)
  192. Evinacumab(3)
  193. Evolocumab(3)
  194. Faralimomab(3)
  195. Farletuzumab(3)
  196. Fasinumab(3)
  197. FD441.8(15)
  198. Felzartamab(3)
  199. Fezakinumab(3)
  200. FGK4.5(19)
  201. FIB21(9)
  202. FIB27(3)
  203. FIB504(24)
  204. Ficlatuzumab(3)
  205. Figitumumab(3)
  206. Fletikumab(3)
  207. Fontolizumab(3)
  208. Foralumab(3)
  209. FR70(11)
  210. Fremanezumab(3)
  211. Fresolimumab(3)
  212. Frunevetmab(3)
  213. Fulranumab(3)
  214. G11(5)
  215. G28.5(19)
  216. G8.8(14)
  217. Galcanezumab(3)
  218. Gantenerumab(3)
  219. Gatralimab(3)
  220. Gemtuzumab(3)
  221. Gevokizumab(3)
  222. Giloralimab(3)
  223. Gimsilumab(3)
  224. GIR 208(9)
  225. Girentuximab(3)
  226. GK1.5(19)
  227. GL1(14)
  228. GL113(3)
  229. Glembatumumab(3)
  230. Grebio(5)
  231. Guselkumab(3)
  232. H22(20)
  233. H57-597(14)
  234. HB-14(7)
  235. HDB-4A7(9)
  236. HEK/1/85a/7a(18)
  237. HK1.4(10)
  238. HK2.1(15)
  239. HK5.3(15)
  240. HKSP(10)
  241. HKSP84(10)
  242. HM48-1(17)
  243. I21/7(15)
  244. I3/2.3(10)
  245. Ibalizumab(3)
  246. ICRF44(5)
  247. Ieramilimab(3)
  248. Ifibio(5)
  249. Ifinatamab(3)
  250. IK22/5(9)
  251. IM7(19)
  252. Indusatumab(3)
  253. Infliximab(3)
  254. Inolimomab(3)
  255. Intetumumab(3)
  256. Ipilimumab(3)
  257. Iratumumab(3)
  258. Isatuximab(3)
  259. Iscalimab(3)
  260. Itepekimab(3)
  261. Itolizumab(3)
  262. Ivuxolimab(3)
  263. Ixekizumab(3)
  264. J43(4)
  265. JAMA-147(10)
  266. JES5-2A5(4)
  267. JES6-1A12(5)
  268. JES6-5H4(4)
  269. Keliximab(3)
  270. L243(10)
  271. Lacnotuzumab(3)
  272. Lebrikizumab(3)
  273. Lemzoparlimab(3)
  274. Lenzilumab(3)
  275. Lerdelimumab(3)
  276. Lintuzumab(3)
  277. LO-CD2a(4)
  278. Lucatumumab(3)
  279. Lulizumab(3)
  280. Lumiliximab(3)
  281. Lusvertikimab(3)
  282. M1/69(8)
  283. M1/70(15)
  284. M290(4)
  285. M5/114.15.2(18)
  286. M5/49.4.1(10)
  287. Magrolimab(3)
  288. MAR 18.5(18)
  289. MAR1-5A3(19)
  290. Margetuximab(3)
  291. Matuzumab(3)
  292. Mavrilimumab(3)
  293. MB22-11(14)
  294. MD5-1(15)
  295. MECA-367(14)
  296. MECA-89(10)
  297. MEL-14(15)
  298. Metelimumab(3)
  299. Mezagitamab(3)
  300. MFL3(18)
  301. MIB-5E9.1(5)
  302. MIG-2F5-5(18)
  303. Minretumomab(3)
  304. Mirikizumab(3)
  305. Mirvetuximab(3)
  306. Mitazalimab(3)
  307. MJ18(18)
  308. MJ7/18(8)
  309. Monalizumab(3)
  310. Motavizumab(3)
  311. MP1-22E9(19)
  312. MP4-25D2(7)
  313. MP5-20F3(4)
  314. MPC-11(10)
  315. MR1(4)
  316. Mupadolimab(3)
  317. Muromonab(3)
  318. N418(5)
  319. Nadunolimab(3)
  320. Namilumab(3)
  321. Naratuximab(3)
  322. Natalizumab(3)
  323. Naxitamab(3)
  324. Necitumumab(3)
  325. Nemolizumab(3)
  326. Nerelimomab(3)
  327. Nesvacumab(3)
  328. Netakimab(3)
  329. Nipocalimab(3)
  330. Nivolumab(3)
  331. Obexelimab(3)
  332. Ocaratuzumab(3)
  333. Odulimomab(3)
  334. Ofatumumab(3)
  335. OKT-4(19)
  336. OKT10(19)
  337. Oleclumab(3)
  338. Olokizumab(3)
  339. Omalizumab(3)
  340. Omburtamab(3)
  341. Onvatilimab(3)
  342. Otelixizumab(3)
  343. Otilimab(3)
  344. OX-26(18)
  345. OX-7(18)
  346. OX-86(19)
  347. OX-90(18)
  348. Ozanezumab(3)
  349. Ozuriftamab(3)
  350. P84(9)
  351. Palivizumab(3)
  352. Pamrevlumab(3)
  353. Panitumumab(3)
  354. Parsatuzumab(3)
  355. Pascolizumab(3)
  356. Patbio(5)
  357. Pateclizumab(3)
  358. Patritumab(3)
  359. PC61(14)
  360. Pembrolizumab(3)
  361. Penpulimab(3)
  362. Perakizumab(3)
  363. Pertuzumab(3)
  364. Pinatuzumab(3)
  365. Pivekimab(3)
  366. PK136(19)
  367. Polatuzumab(3)
  368. Ponezumab(3)
  369. Ponsegromab(3)
  370. PS/2(18)
  371. Quetmolimab(3)
  372. R1-2(3)
  373. R4-6A2(12)
  374. RA3-6B2(19)
  375. Ramucirumab(3)
  376. Ravagalimab(3)
  377. RB6-8C5(19)
  378. Relatlimab(3)
  379. RG9-1(18)
  380. Rilotumumab(3)
  381. Ripertamab(3)
  382. Rituximab(5)
  383. RM134L(14)
  384. RM27-3E5(23)
  385. RMP1-14(26)
  386. RMP1-14-mAbMods(5)
  387. RMP1-14-mAbMods (D265A)(5)
  388. RMP1-14-mAbMods (LALA-PG)(5)
  389. RMP1-30(6)
  390. RMT1-10(14)
  391. RMT3-23(10)
  392. RMT4-53(10)
  393. Robatumumab(3)
  394. Rolinsatamab(3)
  395. Romosozumab(3)
  396. Rontalizumab(3)
  397. Rosopatamab(3)
  398. Rovalpituzumab(3)
  399. Rozanolixizumab(3)
  400. Sabatolimab(3)
  401. Sacituzumab(3)
  402. Sarilumab(3)
  403. Satralizumab(3)
  404. Secukinumab(3)
  405. Selicrelumab(3)
  406. Sifalimumab(3)
  407. Siltuximab(3)
  408. Simtuzumab(3)
  409. Sintilimab(3)
  410. Siplizumab(3)
  411. Sirukumab(3)
  412. SJ25-C1(6)
  413. Sofituzumab(3)
  414. Sotigalimab(3)
  415. Spesolimab(3)
  416. Sutimlimab(3)
  417. Suvizumab(3)
  418. T24/31(19)
  419. T29/33(5)
  420. T3-3A1(5)
  421. T56/14(5)
  422. TA-99(10)
  423. Tabalumab(3)
  424. Tadocizumab(3)
  425. Tafasitamab(3)
  426. Talbio(5)
  427. TAN1-7(19)
  428. Tanezumab(3)
  429. Tecbio(5)
  430. Teneliximab(3)
  431. Teplizumab(3)
  432. Teprotumumab(3)
  433. Tezepelumab(3)
  434. TIF-3C5(9)
  435. Tilavonemab(3)
  436. Tilvestamab(3)
  437. Tinurilimab(3)
  438. Tiragolumab(3)
  439. Tislelizumab(3)
  440. TKS-1(18)
  441. TN3-19.12(19)
  442. Tocilizumab(3)
  443. Toripalimab(3)
  444. Tositumomab(3)
  445. Tovetumab(3)
  446. TR75-54.7(15)
  447. Tralokinumab(3)
  448. Trastuzumab(3)
  449. Tregalizumab(3)
  450. TRFK5(14)
  451. Tusamitamab(3)
  452. TY/23(25)
  453. TY25(9)
  454. Ublituximab(3)
  455. UC10-4F10-11(19)
  456. UC3-10A6(15)
  457. UC7-13D5(10)
  458. UCHL-1(5)
  459. UCHM-1(5)
  460. UCHT-1(10)
  461. UCHT-2(5)
  462. UCHT-4(5)
  463. Uliledlimab(3)
  464. Upifitamab(3)
  465. Urabrelimab(3)
  466. Urelumab(3)
  467. Ustekinumab(3)
  468. Utomilumab(3)
  469. Vadastuximab(3)
  470. Vanalimab(3)
  471. Varisacumab(3)
  472. Varlilumab(3)
  473. Vatelizumab(3)
  474. Vedolizumab(3)
  475. Veltuzumab(3)
  476. Vibostolimab(3)
  477. Visilizumab(3)
  478. VL-4(10)
  479. Volociximab(3)
  480. Vunakizumab(3)
  481. W6/32(15)
  482. Xentuzumab(3)
  483. XMG1.2(19)
  484. Y-3(15)
  485. Y-3P(10)
  486. YN1/1.7.4(19)
  487. YTS-169(19)
  488. YTS191(18)
  489. Zagotenemab(3)
  490. Zalutumumab(3)
  491. Zanolimumab(3)
  492. Zilovertamab(3)
  493. Ziltivekimab(3)
  494. Zinlirvimab(3)
  495. Zolbetuximab(3)
  496. Zolimomab(3)
  497. ZV67(5)
Applications
Isotype
Hersteller

In Vivo Antibodies

13369 Artikel

pro Seite

Seite:
  1. 112
  2. 113
  3. 114
  4. 115
  5. 116
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge ✓ Preis
Vedolizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4035UL-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Vedolizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4035UL-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Durvalumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH5005UL-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Durvalumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH5005UL-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Durvalumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH5005UL-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Durvalumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH5005UL-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Durvalumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH5005UL-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Durvalumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH5005UL-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Monalizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5017UL-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Monalizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5017UL-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Monalizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5017UL-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Monalizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5017UL-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Monalizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5017UL-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Monalizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5017UL-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Magrolimab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5036UL-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Magrolimab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5036UL-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Magrolimab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5036UL-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Magrolimab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5036UL-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Magrolimab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5036UL-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Magrolimab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5036UL-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Tusamitamab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5040UL-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Tusamitamab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5040UL-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Tusamitamab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5040UL-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Tusamitamab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5040UL-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Tusamitamab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5040UL-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Name Preis
Vedolizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Vedolizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 50 mg
Lieferbar
Vedolizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Vedolizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 5 mg
Lieferbar
Durvalumab Biosimilar -­ Ultra Low Endotoxin Anmelden Durvalumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
Durvalumab Biosimilar -­ Ultra Low Endotoxin Anmelden Durvalumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 10 mg
Lieferbar
Durvalumab Biosimilar -­ Ultra Low Endotoxin Anmelden Durvalumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Durvalumab Biosimilar -­ Ultra Low Endotoxin Anmelden Durvalumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 20 mg
Lieferbar
Durvalumab Biosimilar -­ Ultra Low Endotoxin Anmelden Durvalumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 50 mg
Lieferbar
Durvalumab Biosimilar -­ Ultra Low Endotoxin Anmelden Durvalumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 5 mg
Lieferbar
Monalizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Monalizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 100 mg
Lieferbar
Monalizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Monalizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 10 mg
Lieferbar
Monalizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Monalizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 1 mg
Lieferbar
Monalizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Monalizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 20 mg
Lieferbar
Monalizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Monalizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 50 mg
Lieferbar
Monalizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Monalizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 5 mg
Lieferbar
Magrolimab Biosimilar -­ Ultra Low Endotoxin Anmelden Magrolimab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 100 mg
Lieferbar
Magrolimab Biosimilar -­ Ultra Low Endotoxin Anmelden Magrolimab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 10 mg
Lieferbar
Magrolimab Biosimilar -­ Ultra Low Endotoxin Anmelden Magrolimab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 1 mg
Lieferbar
Magrolimab Biosimilar -­ Ultra Low Endotoxin Anmelden Magrolimab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 20 mg
Lieferbar
Magrolimab Biosimilar -­ Ultra Low Endotoxin Anmelden Magrolimab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 50 mg
Lieferbar
Magrolimab Biosimilar -­ Ultra Low Endotoxin Anmelden Magrolimab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 5 mg
Lieferbar
Tusamitamab Biosimilar -­ Ultra Low Endotoxin Anmelden Tusamitamab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 100 mg
Lieferbar
Tusamitamab Biosimilar -­ Ultra Low Endotoxin Anmelden Tusamitamab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 10 mg
Lieferbar
Tusamitamab Biosimilar -­ Ultra Low Endotoxin Anmelden Tusamitamab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 1 mg
Lieferbar
Tusamitamab Biosimilar -­ Ultra Low Endotoxin Anmelden Tusamitamab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 20 mg
Lieferbar
Tusamitamab Biosimilar -­ Ultra Low Endotoxin Anmelden Tusamitamab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 50 mg
Lieferbar

13369 Artikel

pro Seite

Seite:
  1. 112
  2. 113
  3. 114
  4. 115
  5. 116
Kontakt

Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
D-50823 Köln

T +49 221 126 02 66
F +49 221 126 02 67

info@hoelzel.de

Über Hölzel
Service
Infothek
Spendenaktion Datenschutzsiegel

Copyright 2025 Hölzel Diagnostika Handels GmbH

To top